Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Mochida Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	127,442	112,734	114,243	116,879	141,444	164,177
Market Cap Growth	8.94%	-1.32%	-2.25%	-17.37%	-13.85%	1.59%
Enterprise Value	95,945	59,153	70,835	57,234	80,242	103,514
Last Close Price	3595.00	3107.40	3074.34	3113.67	3398.55	3809.95
PE Ratio	19.84	19.83	25.13	17.58	13.38	19.12
Forward PE	-	18.59	20.70	18.73	15.31	20.84
PS Ratio	1.14	1.07	1.11	1.13	1.28	1.59
PB Ratio	0.93	0.86	0.89	0.92	1.10	1.29
P/TBV Ratio	0.94	0.87	0.90	0.93	1.11	1.30
P/FCF Ratio	-	15.67	-	22.78	31.64	22.61
P/OCF Ratio	-	12.05	-	16.02	18.96	17.85
EV/Sales Ratio	0.86	0.56	0.69	0.55	0.73	1.00
EV/EBITDA Ratio	8.40	5.35	8.23	5.12	4.70	7.02
EV/EBIT Ratio	11.45	7.28	12.21	6.73	5.58	8.62
EV/FCF Ratio	-	8.22	-	11.15	17.95	14.25
Net Debt / Equity Ratio	-0.23	-0.39	-0.37	-0.48	-0.48	-0.50
Net Debt / EBITDA Ratio	-2.75	-4.62	-5.43	-5.41	-3.62	-4.30
Net Debt / FCF Ratio	-	-7.11	4.79	-11.79	-13.85	-8.74
Asset Turnover	0.64	0.66	0.65	0.64	0.68	0.65
Inventory Turnover	1.67	1.62	1.86	2.03	2.21	2.02
Quick Ratio	2.72	3.32	3.13	3.24	3.14	3.23
Current Ratio	4.01	4.81	4.47	4.31	4.07	4.14
Return on Equity (ROE)	4.80%	4.40%	3.57%	5.21%	8.27%	6.93%
Return on Assets (ROA)	3.02%	3.19%	2.28%	3.30%	5.54%	4.70%
Return on Invested Capital (ROIC)	8.48%	7.14%	5.81%	9.41%	16.01%	14.10%
Return on Capital Employed (ROCE)	5.50%	6.00%	4.40%	6.50%	10.80%	9.00%
Earnings Yield	5.04%	5.04%	3.98%	5.69%	7.47%	5.23%
FCF Yield	-	6.38%	-8.56%	4.39%	3.16%	4.42%
Dividend Yield	2.23%	2.57%	2.60%	2.57%	2.65%	2.36%
Payout Ratio	-	49.87%	63.49%	50.71%	32.59%	36.14%
Buyback Yield / Dilution	0.00%	1.15%	3.49%	2.47%	1.37%	1.23%
Total Shareholder Return	2.23%	3.72%	6.09%	5.04%	4.02%	3.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.